Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for ...

Novo Nordisk is deeply undervalued, trading at distressed multiples despite a robust pipeline and strong financials. Learn ...

Ionis Pharmaceuticals is a leader in RNA-based therapies. Its spinal muscular atrophy drug Spinraza, marketed by partner Biogen, is the first RNA-based therapy to achieve blockbuster status. The ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be ...

GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...

Victory Capital has put in a bid to buy UK asset manager Janus Henderson, in a move aimed at gatecrashing an earlier deal agreed with Nelson Peltz’s Trian Fund Management and General Catalyst.

Boots in St Albans is among the brand's first high street stores to launch a high street service for weight loss jabs.

Q4 2025 Management View Wendy Barnes, President and CEO, emphasized that "the fourth quarter marked a strong finish to the year and reflected disciplined execution across our strategic priorities." ...

The newly-approved device requires only that patients swallow it in their doctor's office to achieve weight loss, according to Allurion Technologies.

Watch Health Matters: 1 in 4 Canadians living in LTC homes were prescribed anti-psychotic medication without diagnosis, CIHI report says Video Online, on GlobalNews.ca ...